A.E. Whiteley, T.T. Price, G. Cantelli, D.A. Sipkins, Leukaemia: a model metastatic disease. Nat. Rev. Cancer 21, 461–475 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Seth, A. Singh, Leukemias in children. Indian J. Pediatr. 82, 817–824 (2015)

Article  PubMed  Google Scholar 

H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021)

Article  PubMed  Google Scholar 

F. Malard, M. Mohty, Acute lymphoblastic leukaemia. Lancet 395, 1146–1162 (2020)

Article  CAS  PubMed  Google Scholar 

Stat bite: estimated new leukemia cases in 2008. J. Natl. Cancer Inst. 100, 531 (2008)

S.P. Hunger, X. Lu, M. Devidas, B.M. Camitta, P.S. Gaynon, N.J. Winick, G.H. Reaman, W.L. Carroll, Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J. Clin. Oncol. 30, 1663–1669 (2012)

Article  PubMed  PubMed Central  Google Scholar 

D. Pulte, A. Gondos, H. Brenner, Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 113, 1408–1411 (2009)

Article  CAS  PubMed  Google Scholar 

D. Pulte, L. Jansen, A. Gondos, A. Katalinic, B. Barnes, M. Ressing, B. Holleczek, A. Eberle, H. Brenner, G.C.S.W. Group, Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One 9, e85554 (2014)

Article  PubMed  PubMed Central  Google Scholar 

C.H. Pui, D. Campana, D. Pei, W.P. Bowman, J.T. Sandlund, S.C. Kaste, R.C. Ribeiro, J.E. Rubnitz, S.C. Raimondi, M. Onciu, E. Coustan-Smith, L.E. Kun, S. Jeha, C. Cheng, S.C. Howard, V. Simmons, A. Bayles, M.L. Metzger, J.M. Boyett, W. Leung, R. Handgretinger, J.R. Downing, W.E. Evans, M.V. Relling, Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 360, 2730–2741 (2009)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T.A. de Beaumais, E. Jacqz-Aigrain, Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children. Curr. Drug. Metab. 13, 822–834 (2012)

Article  PubMed  Google Scholar 

J.M. Rowe, G. Buck, A.K. Burnett, R. Chopra, P.H. Wiernik, S.M. Richards, H.M. Lazarus, I.M. Franklin, M.R. Litzow, N. Ciobanu, H.G. Prentice, J. Durrant, M.S. Tallman, A.H. Goldstone, Ecog, M.N.A.L.W. Party, Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 106, 3760–3767 (2005)

Article  Google Scholar 

J.J. Cornelissen, D. Blaise, Hematopoietic stem cell transplantation for patients with AML in first complete remission. Blood 127, 62–70 (2016)

Article  CAS  PubMed  Google Scholar 

Y.R. Ma, L.P. Xu, X.H. Zhang, C.H. Yan, Y. Wang, F.R. Wang, J.Z. Wang, Y. Chen, W. Han, Y.H. Chen, H. Chen, K.Y. Liu, X.J. Huang, Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation. Bone Marrow Transplant. 52, 409–414 (2017)

Article  CAS  PubMed  Google Scholar 

A. de Labarthe, P. Rousselot, F. Huguet-Rigal, E. Delabesse, F. Witz, S. Maury, D. Rea, J.M. Cayuela, M.C. Vekemans, O. Reman, A. Buzyn, A. Pigneux, M. Escoffre, Y. Chalandon, E. MacIntyre, V. Lheritier, J.P. Vernant, X. Thomas, N. Ifrah, H. Dombret, L. Group for Research on Adult Acute Lymphoblastic, Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood 109, 1408–1413 (2007)

Article  Google Scholar 

F. Ravandi, S.M. O’Brien, J.E. Cortes, D.M. Thomas, R. Garris, S. Faderl, J.A. Burger, M.E. Rytting, A. Ferrajoli, W.G. Wierda, S. Verstovsek, R. Champlin, P. Kebriaei, D.A. McCue, X. Huang, E. Jabbour, G. Garcia-Manero, Z. Estrov, H.M. Kantarjian, Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 121, 4158–4164 (2015)

Article  CAS  PubMed  Google Scholar 

R.J. Brentjens, M.L. Davila, I. Riviere, J. Park, X. Wang, L.G. Cowell, S. Bartido, J. Stefanski, C. Taylor, M. Olszewska, O. Borquez-ojeda, J. Qu, T. Wasielewska, Q. He, Y. Bernal, I.V. Rijo, C. Hedvat, R. Kobos, K. Curran, P. Steinherz, J. Jurcic, T. Rosenblat, P. Maslak, M. Frattini, M. Sadelain, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl. Med. 5, 177ra138 (2013)

Article  Google Scholar 

N.C. Munshi, L.D. Anderson Jr., N. Shah, D. Madduri, J. Berdeja, S. Lonial, N. Raje, Y. Lin, D. Siegel, A. Oriol, P. Moreau, I. Yakoub-Agha, M. Delforge, M. Cavo, H. Einsele, H. Goldschmidt, K. Weisel, A. Rambaldi, D. Reece, F. Petrocca, M. Massaro, J.N. Connarn, S. Kaiser, P. Patel, L. Huang, T.B. Campbell, K. Hege, J. San-Miguel, Idecabtagene vicleucel in relapsed and refractory multiple myeloma. N. Engl. J. Med. 384, 705–716 (2021)

Article  CAS  PubMed  Google Scholar 

R.C. Sterner, R.M. Sterner, CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021)

Article  PubMed  PubMed Central  Google Scholar 

J.H. Park, I. Riviere, M. Gonen, X. Wang, B. Senechal, K.J. Curran, C. Sauter, Y. Wang, B. Santomasso, E. Mead, M. Roshal, P. Maslak, M. Davila, R.J. Brentjens, M. Sadelain, Long-term follow-up of CD19 CAR therapy in acute lymphoblastic. Leukemia N. Engl. J. Med. 378, 449–459 (2018)

Article  CAS  PubMed  Google Scholar 

S.L. Maude, T.W. Laetsch, J. Buechner, S. Rives, M. Boyer, H. Bittencourt, P. Bader, M.R. Verneris, H.E. Stefanski, G.D. Myers, M. Qayed, B. De Moerloose, H. Hiramatsu, K. Schlis, K.L. Davis, P.L. Martin, E.R. Nemecek, G.A. Yanik, C. Peters, A. Baruchel, N. Boissel, F. Mechinaud, A. Balduzzi, J. Krueger, C.H. June, B.L. Levine, P. Wood, T. Taran, M. Leung, K.T. Mueller, Y. Zhang, K. Sen, D. Lebwohl, M.A. Pulsipher, S.A. Grupp, Tisagenlecleucel in children and young adults with B-cell lymphoblastic Leukemia. N. Engl. J. Med. 378, 439–448 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Bozorgi, M. Bozorgi, M. Khazaei, Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects. Cell Oncol. Dordr. 45, 755–777 (2022)

Article  PubMed  Google Scholar 

M. Akhoundi, M. Mohammadi, S.S. Sahraei, M. Sheykhhasan, N. Fayazi, CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities. Cell Oncol. Dordr. 44, 495–523 (2021)

Article  CAS  PubMed  Google Scholar 

K.M. Murphy, C.A. Nelson, J.R. Sedy, Balancing co-stimulation and inhibition with BTLA and HVEM. Nat. Rev. Immunol. 6, 671–681 (2006)

Article  CAS  PubMed  Google Scholar 

J.I. Rodriguez-Barbosa, P. Schneider, A. Weigert, K.M. Lee, T.J. Kim, J.A. Perez-Simon, M.L. Del Rio, HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT. Cell Mol. Immunol. 16, 679–682 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T.L. Murphy, K.M. Murphy, Slow down and survive: enigmatic immunoregulation by BTLA and HVEM. Annu. Rev. Immunol. 28, 389–411 (2010)

Article  CAS  PubMed  Google Scholar 

N. Watanabe, M. Gavrieli, J.R. Sedy, J. Yang, F. Fallarino, S.K. Loftin, M.A. Hurchla, N. Zimmerman, J. Sim, X. Zang, T.L. Murphy, J.H. Russell, J.P. Allison, K.M. Murphy, BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4, 670–679 (2003)

Article  CAS  PubMed  Google Scholar 

L.C. Gonzalez, K.M. Loyet, J. Calemine-Fenaux, V. Chauhan, B. Wranik, W. Ouyang, D.L. Eaton, A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. U. S. A. 102, 1116–1121 (2005)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T. Duhen, C. Pasero, F. Mallet, B. Barbarat, D. Olive, R.T. Costello, LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation. Eur. J. Immunol. 34, 3534–3541 (2004)

Article  CAS  PubMed  Google Scholar 

Y. Morel, A. Truneh, R.W. Sweet, D. Olive, R.T. Costello, The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 167, 2479–2486 (2001)

Article  CAS  PubMed  Google Scholar 

D.N. Mauri, R. Ebner, R.I. Montgomery, K.D. Kochel, T.C. Cheung, G.L. Yu, S. Ruben, M. Murphy, R.J. Eisenberg, G.H. Cohen, P.G. Spear, C.F. Ware, LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8, 21–30 (1998)

Article  CAS  PubMed  Google Scholar 

R.J. Schilder, J.D. Powderly, H. Park, M.A. Bilen, M. McKean, R. May, H. Feng, S. Yao, P. Keegan, A. Naing, Phase Ia dose-escalation study of the anti-BTLA antibody icatolimab as a monotherapy in patients with advanced solid tumor. J. Clin. Oncol. 40 (2022)

Z. Wang, L. Wu, B. Li, Y. Cheng, X. Li, X. Wang, L. Han, X. Wu, Y. Fan, Y. Yu, D. Lv, J. Shi, J. Huang, S. Zhou, B. Han, G. Sun, Q. Guo, Y. Ji, X. Zhu, S. Hu, W. Zhang, Q. Wang, Y. Jia, Z. Wang, Y. Song, J. Wu, M. Shi, X. Li, Z. Han, Y. Liu, Z. Yu, A.W. Liu, X. Wang, C. Zhou, D. Zhong, L. Miao, Z. Zhang, H. Zhao, J. Yang, D. Wang, Y. Wang, Q. Li, X. Zhang, M. Ji, Z. Yang, J. Cui, B. Gao, B. Wang, H. Liu, L. Nie, M. He, S. Jin, W. Gu, Y. Shu, T. Zhou, J. Feng, X. Yang, C. Huang, B. Zhu, Y. Yao, X. Tang, J. Yu, E. Maher, H. Feng, S. Yao, P. Keegan, J. Wang, Toripalimab plus chemotherapy for patients with treatment-naive advanced non-small-cell lung cancer: a multicenter randomized phase III trial (CHOICE-01). J. Clin. Oncol. 41, 651–663 (2023)

Article  CAS  PubMed  Google Scholar 

P.G. Spear, Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol. 6, 401–410 (2004)

Article  CAS  PubMed  Google Scholar 

N. Malissen, N. Macagno, S. Granjeaud, C. Granier, V. Moutardier, C. Gaudy-Marqueste, N. Habel, M. Mandavit, B. Guillot, C. Pasero, E. Tartour, R. Ballotti, J.J. Grob, D. Olive, HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. Oncoimmunology 8, e1665976 (2019)